DrugId:  1
1. Name:  LC16M8
2. Groups:  Investigational
3. Description:  LC16m8 is a next-generation, attenuated smallpox vaccine that is designed to have a better safety profile, yet be equally effective, compared to conventional smallpox vaccines. It is the only attenuated vaccine to be licensed for use in humans to prevent smallpox infection. 
4. Indication:  Investigated for use/treatment in viral infection.
DrugId:  2
1. Name:  Vidarabine
2. Groups:  Approved, Investigational
3. Description:  A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the vaccinia VIRUS and varicella zoster virus. [PubChem]
4. Indication:  For treatment of chickenpox - varicella, herpes zoster and herpes simplex
